-
利益冲突 无
-
图 1 图 1腹部盆腔增强CT及胰腺薄层扫描见胰腺呈弥漫性肿大(A,箭头),周围脂肪密度影增高,脾静脉中段管腔重度狭窄,胆总管管壁全程环形增厚,下段管腔狭窄(B,箭头),狭窄处以上肝内外胆管明显扩张
图 3 原发性硬化性胆管炎(A)与IgG4相关性硬化性胆管炎(B)胆管狭窄特点示意图[5]
图 7 IgG4-RD(AIP/IgG4-SC)与胰腺癌/胆管下段癌鉴别流程图[16]
IgG4-RD:IgG4相关性疾病;AIP:自身免疫性胰腺炎;IgG4-SC:IgG4相关性硬化性胆管炎;MRI:磁共振成像;OOI:其他器官受累
-
[1] Umehare H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD)[J]. Mod Rheumatol, 2012, 22: 21-30. doi: 10.3109/s10165-011-0571-z [2] Khosroshahi A, Wallace ZS, Crowe JL, et al. Interna-tional consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67: 1688-1699. doi: 10.1002/art.39132 [3] Kazuichi O, Suresh TC, Luca F, et al. International consensus for the treatment of autoimmune pancreatitis[J]. Pancreatology, 2017, 17: 1-6. doi: 10.1016/j.pan.2016.12.003 [4] Shounak M, Naoki T, Suresh TC. Autoimmune Pancreatitis[J]. Dig Dis Sci, 2017, 62: 1762-1769. doi: 10.1007/s10620-017-4541-y [5] Ohara H, Okazaki K, Tsubouchi H, et al. Clinical diagnostic criteria of IgG4-related sclerosing cholangitis[J]. J Hepatobiliary Pancreat Sci, 2012, 19: 536-542. doi: 10.1007/s00534-012-0521-y [6] Liu W, Liu Q, Wang W, et al. Differential diagnostic roles of the serum CA19-9, total bilirubin (TBIL) and the ratio of CA19-9 to TBIL for benign and malignant[J]. J Cancer, 2018, 9: 1804-1812. doi: 10.7150/jca.25093 [7] Von RC, Eder MI, Stieber P, et al. Biliary mucin secreted by cultured human gallbladder epithelial cells carries the epitope of CA19-9[J]. Anticancer Res, 1997, 17: 2931-2934. https://www.ncbi.nlm.nih.gov/pubmed/9329567 [8] Mann DV, Edwards R, Ho S, et al. Elevated tumour marker CA19-9: clinical interpretation and influence of obstructive jaundice[J]. Eur J Surg Oncol, 2000, 26: 474-479. doi: 10.1053/ejso.1999.0925 [9] Carruthers MN, Stone JH, Deshpande V, et al. Development of an IgG4-RD Responder Index[J]. Int J Rheumatol, 2012, 2012:259408. [10] Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease[J]. Lancet, 2015, 385: 1460-1471. doi: 10.1016/S0140-6736(14)60720-0 [11] 张盼盼, 赵继志, 王木, 等. IgG4相关性疾病346例临床特征分析[J].中华内科杂志, 2017, 56: 644-649. doi: 10.3760/cma.j.issn.0578-1426.2017.09.005 [12] 赖亚敏, 吴东, 杨红, 等. 1型自身免疫性胰腺炎的流行病学及临床特点[J].基础医学与临床, 2017, 37: 1607-1610. doi: 10.3969/j.issn.1001-6325.2017.11.021 [13] 冯云路, 杨爱明, 姚方, 等.36例IgG4相关硬化性胆管炎临床特点[J].协和医学杂志, 2015, 2:102-105. doi: 10.3969/j.issn.1674-9081.2015.02.005 [14] Asbun HJ, Conlon K, Fernandezcruz L, et al. When to perform a pancreatoduodenectomy in the absence of positive histology? A consensus statement by the International Study Group of Pancreatic Surgery[J]. Surgery, 2014, 155: 887-892. doi: 10.1016/j.surg.2013.12.032 [15] van Heerde MJ, Biermann K, Zondervan PE, et al. Preva-lence of autoimmune pancreatitis and other benign disorders in pancreatoduodenectomy for presumed malignancy of the pancreatic head[J]. Dig Dis Sci, 2012, 57: 2458-2465. doi: 10.1007/s10620-012-2191-7 [16] Chari ST, Takahashi N, Levy MJ, et al.A diagnostic stra-tegy to distinguish autoimmune pancreatitis from pancreatic cancer[J]. Clin Gastroenterol Hepatol, 2009, 7:1097-1103. doi: 10.1016/j.cgh.2009.04.020 [17] 张奉春.风湿免疫性疾病:我们需要了解什么[J].协和医学杂志, 2017, 8:204-206. doi: 10.3969/j.issn.1674-9081.2017.05.002 -